Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 50.18 | (627.96) | (478.40)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 158.06 | (640.93) | (481.19)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 389.22 | (464.96) | (310.61)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
Currency | US Dollars |
Share Price | $ 38.05 |
Change Today | $ 0.73 |
% Change | 1.96 % |
52 Week High | $58.62 |
52 Week Low | $29.84 |
Volume | 1,022,959 |
Shares Issued | 55.37m |
Market Cap | $2,106.95m |
Beta | 0.34 |
RiskGrade | 332 |
Strong Buy | 4 |
Buy | 12 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
16:00 | 110,512 @ $38.05 |
15:59 | 168 @ $38.04 |
15:59 | 1,104 @ $38.04 |
15:59 | 144 @ $38.04 |
15:59 | 209 @ $38.04 |
You are here: research